Global Plastic Pre-Filled Syringes Market by Product (Needle-free Pre-filled Syringe, and Needled Prefilled Syringe), Polymer Type [COP (Cyclic Olefin Polymer), COC (Cyclic Olefin Copolymer), and Polypropylene (PP)], Design (Single-chamber Prefilled Syringes, and Dual-chamber Prefilled Syringes), Application (Diabetes, Rheumatoid Arthritis, Anaphylaxis, Cancer, Thrombosis, Ophthalmology, and Others), End-user (Hospital, Clinics, Home Care, and Others) and Regions (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Global Industry Analysis, Growth, Shares, Size, Trends, and Forecast 2022-2030
Plastic Pre-Filled Syringes Market Outlook
The Global Plastic Pre-Filled Syringes Market was estimated at USD 1,843.8 Mn in 2021 and is anticipated to reach USD 3,764.1 Mn by 2030, expanding at a CAGR of 8.8% during the forecast period.
Plastic is one of the widely used Polymer Types for making syringes, as it is durable, lightweight, and resistant to chemicals. Plastic pre-filled syringes are medical devices used to deliver precise dosages of medication to patients. It consists of a plastic barrel, plunger, and needle, all of which are pre-assembled and pre-sterilized.
The medication is filled into the syringe, eliminating the need for healthcare professionals to manually draw the medication from a vial or ampoule. Plastic pre-filled syringes are commonly used in a variety of medical settings, including hospitals and clinics, for efficient drug delivery.
Macro-economic Factors
Increasing Healthcare Expenditure
Healthcare expenditure refers to the amount of money spent on healthcare goods and services, such as medical treatments, hospitalizations, medical equipment, and other healthcare-related expenses. This includes both public and private spending on healthcare, such as expenditure by governments, insurance companies, and individuals.
High healthcare spending leads to high investment in new and innovative medical technologies, such as pre-filled syringes. The overall level of healthcare spending in a given region impacts the adoption of plastic pre-filled syringes.
GDP
The per capita income of the population is increasing significantly over time. The production and consumption of plastic pre-filled syringes is part of a country’s economic activity and are highly influenced by changes in GDP.
Growing GDP leads to an increase in the demand for healthcare products, including plastic pre-filled syringes, however, people have more disposable income to spend on medical treatments. Additionally, a higher level of GDP leads to an improvement in healthcare infrastructure and access to medical care, which contribute to the growth of the plastic prefilled syringes market.
Plastic Pre-Filled Syringes Market Dynamics
Market Driver
-
Increasing Prevalence of Chronic Diseases
Chronic diseases are long-term health conditions that typically develop over a period of time and persist for extended periods. These are major public health concerns globally. According to National Health Council, generally incurable and ongoing chronic diseases affect approximately 133 million people in the US, representing more than 40% of the total population of this country.
For instance, in 2009, 7 out of 10 deaths in the US are attributed to chronic diseases. Heart disease, cancer, and stroke account for more than half of all deaths each year. The global plastic pre-filled syringes market is anticipated to expand at a considerable rate, due to the rising prevalence of chronic diseases globally and the growing demand for self-administered drugs.
-
Government Initiatives for Efficient Drug Delivery
Governments around the world are implementing policies and initiatives to ensure the uninterrupted availability of drugs in the public health system, along with the safety of the patients and a well-functioning health system. Initiatives taken by governmental bodies are aimed at improving healthcare infrastructure and increasing access to healthcare in developing countries, which is driving the market.
Pre-filled syringes provide high patient safety by reducing the potential for inadvertent needle sticks and exposure to toxic products that occur while drawing medication from vials. Prefilled syringes, with their pre-measured dosage, reduce dosing errors and increase patient compliance.
For instance, initiatives such as National Health Protection Scheme in India, aim to provide healthcare coverage for over 10 crore poor and vulnerable families, driving the demand for prefilled syringes. Furthermore, rising healthcare access in different locations is boosting the demand for necessary healthcare equipment, such as pre-filled syringes.
Market Restraint
Limited Drug Compatibility
Pharmaceutical companies ensure patient safety by demonstrating that no component or Polymer Type has any extractable and leachable (E&L) and that the primary packaging does not have a negative or adverse interaction with the drugs. Some E&L have the potential to interact with therapeutic molecules and reduce a drug's efficacy. In ampoules, the drug is in contact with the glass. Moreover, the medication comes into contact with glass and rubber inside vials.
Pre-filled syringes come into contact with various Polymer Types and components in addition to the medicine, which increases the potential for interactions and E&L. Additionally, these syringes are made of a specific Polymer Type that is not compatible with certain drugs, leading to the degradation of the drug or the formation of particles that clog the needle or cause an adverse reaction.
Market Opportunity
Advancement in Technology of Drug Delivery Systems
Technology refers to innovations and inventions that are purposely designed to improve efficiency and effectiveness in various fields. In healthcare, drug delivery system technology has made remarkable progress in the past few years, transforming how medical professionals diagnose, treat, and manage the disease.
Over the years, significant technological advancements took place in plastic pre-filled syringes, making them increasingly popular for various purposes, including the delivery of vaccines and other injectable drugs. The development of high-quality, medical-grade plastics led to the production of syringes that are durable, reliable, and safe for use in healthcare settings. Pre-filled syringes provide a wide range of advantages that make them popular, including convenience, adaptability for home usage, and high dosage accuracy.
Scope of Plastic Pre-Filled Syringes Market Report
The report on the global Plastic Pre-Filled Syringes market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
Plastic Pre-Filled Syringes Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast |
Base Year |
2021 |
Historic Data |
2015–2020 |
Forecast Period |
2022–2030 |
Segmentation |
Product (Needle-free Pre-filled Syringe, and Needled Prefilled Syringe), Polymer Type (COP (Cyclic Olefin Polymer), COC (Cyclic Olefin Copolymer), and Polypropylene (PP)), Design (Single-chamber Prefilled Syringes, and Dual-chamber Prefilled Syringes), Application (Diabetes, Rheumatoid Arthritis, Anaphylaxis, Cancer, Thrombosis, Ophthalmology, and Others), End-user (Hospital, Clinics, Home Care, and Others) |
Regional Scope |
Regions (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
Key Players Covered |
BD, Baxter International Inc., Gerresheimer Group, Fresenius SE & Co. KGaA., Nipro Corporation, SCHOTT AG, Taisei Kako Co., Ltd., Terumo Corporation, Plas-Tech Engineering, Inc., and West Pharmaceutical Services, Inc. |
Plastic Pre-Filled Syringes Market Segmental Outlook
Based on product, the market is segmented into needle-free pre-filled syringe and needled prefilled syringe. The needle-free pre-filled syringe segment is expected to hold a considerable share of the market during the forecast, as it is a quick and efficient method of administration, and reduces the uneasiness of administering medicine.
On the basis of polymer type, the market is fragmented into cyclo olefin polymer (COP), cyclic olefin copolymer (COC), and polypropylene (PP). The COP (Cyclic Olefin Polymer) segment holds a key share of the market, as it is more clinically safe and cost-effective and offers better optical transparency & barrier properties than glass.
In terms of design, the market is classified into single-chamber pre-filled syringes and dual-chamber pre-filled syringes. The single-chamber pre-filled syringes segment is anticipated to expand at a significant CAGR during the forecast period. Single-chamber prefilled syringes are used to inject pre-filled vaccines, biological products, or pharmaceutical products, which is anticipated to drive the demand for single-chamber plastic pre-filled syringes segment.
In terms of application, the market is classified into diabetes, rheumatoid arthritis, anaphylaxis, cancer, thrombosis, ophthalmology, and others. The diabetes segment is anticipated to expand at a significant CAGR during the forecast period, owing to increasing cases of diabetes worldwide, that are treated with pre-filled syringes.
On the basis of end-user, the market is fragmented into hospitals, clinics, home care, and others. The hospital segment holds a key share of the market, due to the growing admissions of patients suffering from cardiovascular diseases, diabetes, and cancer in hospitals.
Plastic Pre-Filled Syringes Market Regional Outlook
Based on regions, the market is fragmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for a significant share of the market in 2021, due to the high demand for pre-filled syringes that are mostly used to treat diabetes. More than 37 million people in the US have diabetes, and 1 in 5 affected people are still unaware of it.
Key Benefits for Industry Participants & Stakeholders
- In-depth Analysis of the Global Plastic Pre-Filled Syringes Market
- Historical, Current, and Projected Market Size in Terms of Value
- Potential & Niche Segments and Regions Exhibiting Promising Growth Covered
- Industry Drivers, Restraints, and Opportunities Covered in the Study
- Recent Industry Trends and Developments
- Competitive Landscape & Strategies of Key Players
- Neutral Perspective on Global Plastic Pre-Filled Syringes Market Performance
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Plastic Pre-filled Syringes Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Plastic Pre-filled Syringes Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Plastic Pre-filled Syringes Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Plastic Pre-filled Syringes Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Plastic Pre-filled Syringes Market Size & Forecast, 2016-2031
4.5.1 Plastic Pre-filled Syringes Market Size and Y-o-Y Growth
4.5.2 Plastic Pre-filled Syringes Market Absolute $ Opportunity
4.6 Global Plastic Prefilled Syringe Market: Current and Future Market Trends
4.7 Global Plastic Prefilled Syringe Market: Clinical Trial Overview
4.8 Global Plastic Prefilled Syringe Market: Patent Analysis
4.9 Comparative Analysis: Prefilled Syringes vs Autoinjectors
4.10 Syringe Fill and Polish Process: Overview
Chapter 5 Global Plastic Pre-filled Syringes Market Analysis and Forecast By Product
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities By Product
5.1.2 Basis Point Share (BPS) Analysis By Product
5.1.3 Absolute $ Opportunity Assessment By Product
5.2 Plastic Pre-filled Syringes Market Size Forecast By Product
5.2.1 Needle-Free Prefilled Syringe
5.2.2 Needled Prefilled Syringe
5.3 Market Attractiveness Analysis By Product
Chapter 6 Global Plastic Pre-filled Syringes Market Analysis and Forecast By Polymer Type
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities By Polymer Type
6.1.2 Basis Point Share (BPS) Analysis By Polymer Type
6.1.3 Absolute $ Opportunity Assessment By Polymer Type
6.2 Plastic Pre-filled Syringes Market Size Forecast By Polymer Type
6.2.1 COP (Cyclic Olefin Polymer)
6.2.2 COC (Cyclic Olefin Copolymer)
6.2.3 Polypropylene (PP)
6.3 Market Attractiveness Analysis By Polymer Type
Chapter 7 Global Plastic Pre-filled Syringes Market Analysis and Forecast By Design
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities By Design
7.1.2 Basis Point Share (BPS) Analysis By Design
7.1.3 Absolute $ Opportunity Assessment By Design
7.2 Plastic Pre-filled Syringes Market Size Forecast By Design
7.2.1 Single-chamber Prefilled Syringes
7.2.2 Dual-chamber Prefilled Syringes
7.3 Market Attractiveness Analysis By Design
Chapter 8 Global Plastic Pre-filled Syringes Market Analysis and Forecast By Application
8.1 Introduction
8.1.1 Key Market Trends & Growth Opportunities By Application
8.1.2 Basis Point Share (BPS) Analysis By Application
8.1.3 Absolute $ Opportunity Assessment By Application
8.2 Plastic Pre-filled Syringes Market Size Forecast By Application
8.2.1 Diabetes
8.2.2 Rheumatoid Arthritis
8.2.3 Anaphylaxis
8.2.4 Cancer
8.2.5 Thrombosis
8.2.6 Ophthalmology
8.2.7 Others
8.3 Market Attractiveness Analysis By Application
Chapter 9 Global Plastic Pre-filled Syringes Market Analysis and Forecast By End-user
9.1 Introduction
9.1.1 Key Market Trends & Growth Opportunities By End-user
9.1.2 Basis Point Share (BPS) Analysis By End-user
9.1.3 Absolute $ Opportunity Assessment By End-user
9.2 Plastic Pre-filled Syringes Market Size Forecast By End-user
9.2.1 Hospital
9.2.2 Clinics
9.2.3 Home Care
9.2.4 Others
9.3 Market Attractiveness Analysis By End-user
Chapter 10 Global Plastic Pre-filled Syringes Market Analysis and Forecast by Region
10.1 Introduction
10.1.1 Key Market Trends & Growth Opportunities by Region
10.1.2 Basis Point Share (BPS) Analysis by Region
10.1.3 Absolute $ Opportunity Assessment by Region
10.2 Plastic Pre-filled Syringes Market Size Forecast by Region
10.2.1 North America
10.2.2 Europe
10.2.3 Asia Pacific
10.2.4 Latin America
10.2.5 Middle East & Africa (MEA)
10.3 Market Attractiveness Analysis by Region
Chapter 11 Coronavirus Disease (COVID-19) Impact
11.1 Introduction
11.2 Current & Future Impact Analysis
11.3 Economic Impact Analysis
11.4 Government Policies
11.5 Investment Scenario
Chapter 12 North America Plastic Pre-filled Syringes Analysis and Forecast
12.1 Introduction
12.2 North America Plastic Pre-filled Syringes Market Size Forecast by Country
12.2.1 U.S.
12.2.2 Canada
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 North America Plastic Pre-filled Syringes Market Size Forecast By Product
12.6.1 Needle-Free Prefilled Syringe
12.6.2 Needled Prefilled Syringe
12.7 Basis Point Share (BPS) Analysis By Product
12.8 Absolute $ Opportunity Assessment By Product
12.9 Market Attractiveness Analysis By Product
12.10 North America Plastic Pre-filled Syringes Market Size Forecast By Polymer Type
12.10.1 COP (Cyclic Olefin Polymer)
12.10.2 COC (Cyclic Olefin Copolymer)
12.10.3 Polypropylene (PP)
12.11 Basis Point Share (BPS) Analysis By Polymer Type
12.12 Absolute $ Opportunity Assessment By Polymer Type
12.13 Market Attractiveness Analysis By Polymer Type
12.14 North America Plastic Pre-filled Syringes Market Size Forecast By Design
12.14.1 Single-chamber Prefilled Syringes
12.14.2 Dual-chamber Prefilled Syringes
12.15 Basis Point Share (BPS) Analysis By Design
12.16 Absolute $ Opportunity Assessment By Design
12.17 Market Attractiveness Analysis By Design
12.18 North America Plastic Pre-filled Syringes Market Size Forecast By Application
12.18.1 Diabetes
12.18.2 Rheumatoid Arthritis
12.18.3 Anaphylaxis
12.18.4 Cancer
12.18.5 Thrombosis
12.18.6 Ophthalmology
12.18.7 Others
12.19 Basis Point Share (BPS) Analysis By Application
12.20 Absolute $ Opportunity Assessment By Application
12.21 Market Attractiveness Analysis By Application
12.22 North America Plastic Pre-filled Syringes Market Size Forecast By End-user
12.22.1 Hospital
12.22.2 Clinics
12.22.3 Home Care
12.22.4 Others
12.23 Basis Point Share (BPS) Analysis By End-user
12.24 Absolute $ Opportunity Assessment By End-user
12.25 Market Attractiveness Analysis By End-user
Chapter 13 Europe Plastic Pre-filled Syringes Analysis and Forecast
13.1 Introduction
13.2 Europe Plastic Pre-filled Syringes Market Size Forecast by Country
13.2.1 Germany
13.2.2 France
13.2.3 Italy
13.2.4 U.K.
13.2.5 Spain
13.2.6 Russia
13.2.7 Rest of Europe
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Europe Plastic Pre-filled Syringes Market Size Forecast By Product
13.6.1 Needle-Free Prefilled Syringe
13.6.2 Needled Prefilled Syringe
13.7 Basis Point Share (BPS) Analysis By Product
13.8 Absolute $ Opportunity Assessment By Product
13.9 Market Attractiveness Analysis By Product
13.10 Europe Plastic Pre-filled Syringes Market Size Forecast By Polymer Type
13.10.1 COP (Cyclic Olefin Polymer)
13.10.2 COC (Cyclic Olefin Copolymer)
13.10.3 Polypropylene (PP)
13.11 Basis Point Share (BPS) Analysis By Polymer Type
13.12 Absolute $ Opportunity Assessment By Polymer Type
13.13 Market Attractiveness Analysis By Polymer Type
13.14 Europe Plastic Pre-filled Syringes Market Size Forecast By Design
13.14.1 Single-chamber Prefilled Syringes
13.14.2 Dual-chamber Prefilled Syringes
13.15 Basis Point Share (BPS) Analysis By Design
13.16 Absolute $ Opportunity Assessment By Design
13.17 Market Attractiveness Analysis By Design
13.18 Europe Plastic Pre-filled Syringes Market Size Forecast By Application
13.18.1 Diabetes
13.18.2 Rheumatoid Arthritis
13.18.3 Anaphylaxis
13.18.4 Cancer
13.18.5 Thrombosis
13.18.6 Ophthalmology
13.18.7 Others
13.19 Basis Point Share (BPS) Analysis By Application
13.20 Absolute $ Opportunity Assessment By Application
13.21 Market Attractiveness Analysis By Application
13.22 Europe Plastic Pre-filled Syringes Market Size Forecast By End-user
13.22.1 Hospital
13.22.2 Clinics
13.22.3 Home Care
13.22.4 Others
13.23 Basis Point Share (BPS) Analysis By End-user
13.24 Absolute $ Opportunity Assessment By End-user
13.25 Market Attractiveness Analysis By End-user
Chapter 14 Asia Pacific Plastic Pre-filled Syringes Analysis and Forecast
14.1 Introduction
14.2 Asia Pacific Plastic Pre-filled Syringes Market Size Forecast by Country
14.2.1 China
14.2.2 Japan
14.2.3 South Korea
14.2.4 India
14.2.5 Australia
14.2.6 South East Asia (SEA)
14.2.7 Rest of Asia Pacific (APAC)
14.3 Basis Point Share (BPS) Analysis by Country
14.4 Absolute $ Opportunity Assessment by Country
14.5 Market Attractiveness Analysis by Country
14.6 Asia Pacific Plastic Pre-filled Syringes Market Size Forecast By Product
14.6.1 Needle-Free Prefilled Syringe
14.6.2 Needled Prefilled Syringe
14.7 Basis Point Share (BPS) Analysis By Product
14.8 Absolute $ Opportunity Assessment By Product
14.9 Market Attractiveness Analysis By Product
14.10 Asia Pacific Plastic Pre-filled Syringes Market Size Forecast By Polymer Type
14.10.1 COP (Cyclic Olefin Polymer)
14.10.2 COC (Cyclic Olefin Copolymer)
14.10.3 Polypropylene (PP)
14.11 Basis Point Share (BPS) Analysis By Polymer Type
14.12 Absolute $ Opportunity Assessment By Polymer Type
14.13 Market Attractiveness Analysis By Polymer Type
14.14 Asia Pacific Plastic Pre-filled Syringes Market Size Forecast By Design
14.14.1 Single-chamber Prefilled Syringes
14.14.2 Dual-chamber Prefilled Syringes
14.15 Basis Point Share (BPS) Analysis By Design
14.16 Absolute $ Opportunity Assessment By Design
14.17 Market Attractiveness Analysis By Design
14.18 Asia Pacific Plastic Pre-filled Syringes Market Size Forecast By Application
14.18.1 Diabetes
14.18.2 Rheumatoid Arthritis
14.18.3 Anaphylaxis
14.18.4 Cancer
14.18.5 Thrombosis
14.18.6 Ophthalmology
14.18.7 Others
14.19 Basis Point Share (BPS) Analysis By Application
14.20 Absolute $ Opportunity Assessment By Application
14.21 Market Attractiveness Analysis By Application
14.22 Asia Pacific Plastic Pre-filled Syringes Market Size Forecast By End-user
14.22.1 Hospital
14.22.2 Clinics
14.22.3 Home Care
14.22.4 Others
14.23 Basis Point Share (BPS) Analysis By End-user
14.24 Absolute $ Opportunity Assessment By End-user
14.25 Market Attractiveness Analysis By End-user
Chapter 15 Latin America Plastic Pre-filled Syringes Analysis and Forecast
15.1 Introduction
15.2 Latin America Plastic Pre-filled Syringes Market Size Forecast by Country
15.2.1 Brazil
15.2.2 Mexico
15.2.3 Rest of Latin America (LATAM)
15.3 Basis Point Share (BPS) Analysis by Country
15.4 Absolute $ Opportunity Assessment by Country
15.5 Market Attractiveness Analysis by Country
15.6 Latin America Plastic Pre-filled Syringes Market Size Forecast By Product
15.6.1 Needle-Free Prefilled Syringe
15.6.2 Needled Prefilled Syringe
15.7 Basis Point Share (BPS) Analysis By Product
15.8 Absolute $ Opportunity Assessment By Product
15.9 Market Attractiveness Analysis By Product
15.10 Latin America Plastic Pre-filled Syringes Market Size Forecast By Polymer Type
15.10.1 COP (Cyclic Olefin Polymer)
15.10.2 COC (Cyclic Olefin Copolymer)
15.10.3 Polypropylene (PP)
15.11 Basis Point Share (BPS) Analysis By Polymer Type
15.12 Absolute $ Opportunity Assessment By Polymer Type
15.13 Market Attractiveness Analysis By Polymer Type
15.14 Latin America Plastic Pre-filled Syringes Market Size Forecast By Design
15.14.1 Single-chamber Prefilled Syringes
15.14.2 Dual-chamber Prefilled Syringes
15.15 Basis Point Share (BPS) Analysis By Design
15.16 Absolute $ Opportunity Assessment By Design
15.17 Market Attractiveness Analysis By Design
15.18 Latin America Plastic Pre-filled Syringes Market Size Forecast By Application
15.18.1 Diabetes
15.18.2 Rheumatoid Arthritis
15.18.3 Anaphylaxis
15.18.4 Cancer
15.18.5 Thrombosis
15.18.6 Ophthalmology
15.18.7 Others
15.19 Basis Point Share (BPS) Analysis By Application
15.20 Absolute $ Opportunity Assessment By Application
15.21 Market Attractiveness Analysis By Application
15.22 Latin America Plastic Pre-filled Syringes Market Size Forecast By End-user
15.22.1 Hospital
15.22.2 Clinics
15.22.3 Home Care
15.22.4 Others
15.23 Basis Point Share (BPS) Analysis By End-user
15.24 Absolute $ Opportunity Assessment By End-user
15.25 Market Attractiveness Analysis By End-user
Chapter 16 Middle East & Africa (MEA) Plastic Pre-filled Syringes Analysis and Forecast
16.1 Introduction
16.2 Middle East & Africa (MEA) Plastic Pre-filled Syringes Market Size Forecast by Country
16.2.1 Saudi Arabia
16.2.2 South Africa
16.2.3 UAE
16.2.4 Rest of Middle East & Africa (MEA)
16.3 Basis Point Share (BPS) Analysis by Country
16.4 Absolute $ Opportunity Assessment by Country
16.5 Market Attractiveness Analysis by Country
16.6 Middle East & Africa (MEA) Plastic Pre-filled Syringes Market Size Forecast By Product
16.6.1 Needle-Free Prefilled Syringe
16.6.2 Needled Prefilled Syringe
16.7 Basis Point Share (BPS) Analysis By Product
16.8 Absolute $ Opportunity Assessment By Product
16.9 Market Attractiveness Analysis By Product
16.10 Middle East & Africa (MEA) Plastic Pre-filled Syringes Market Size Forecast By Polymer Type
16.10.1 COP (Cyclic Olefin Polymer)
16.10.2 COC (Cyclic Olefin Copolymer)
16.10.3 Polypropylene (PP)
16.11 Basis Point Share (BPS) Analysis By Polymer Type
16.12 Absolute $ Opportunity Assessment By Polymer Type
16.13 Market Attractiveness Analysis By Polymer Type
16.14 Middle East & Africa (MEA) Plastic Pre-filled Syringes Market Size Forecast By Design
16.14.1 Single-chamber Prefilled Syringes
16.14.2 Dual-chamber Prefilled Syringes
16.15 Basis Point Share (BPS) Analysis By Design
16.16 Absolute $ Opportunity Assessment By Design
16.17 Market Attractiveness Analysis By Design
16.18 Middle East & Africa (MEA) Plastic Pre-filled Syringes Market Size Forecast By Application
16.18.1 Diabetes
16.18.2 Rheumatoid Arthritis
16.18.3 Anaphylaxis
16.18.4 Cancer
16.18.5 Thrombosis
16.18.6 Ophthalmology
16.18.7 Others
16.19 Basis Point Share (BPS) Analysis By Application
16.20 Absolute $ Opportunity Assessment By Application
16.21 Market Attractiveness Analysis By Application
16.22 Middle East & Africa (MEA) Plastic Pre-filled Syringes Market Size Forecast By End-user
16.22.1 Hospital
16.22.2 Clinics
16.22.3 Home Care
16.22.4 Others
16.23 Basis Point Share (BPS) Analysis By End-user
16.24 Absolute $ Opportunity Assessment By End-user
16.25 Market Attractiveness Analysis By End-user
Chapter 17 Competition Landscape
17.1 Plastic Pre-filled Syringes Market: Competitive Dashboard
17.2 Global Plastic Pre-filled Syringes Market: Market Share Analysis, 2022
17.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
17.3.1 Baxter International Inc.
17.3.2 BD
17.3.3 Fresenius SE & Co. KGaA.
17.3.4 Gerresheimer Group
17.3.5 Nipro Corporation
17.3.6 Plas-Tech Engineering, Inc.
17.3.7 SCHOTT AG
17.3.8 Taisei Kako Co., Ltd.
17.3.9 Terumo Corporation
17.3.10 West Pharmaceutical Services, Inc.